217 related articles for article (PubMed ID: 26625757)
21. Genetic susceptibility of epidermal growth factor +61A>G and transforming growth factor beta1 -509C>T gene polymorphisms with gallbladder cancer.
Vishnoi M; Pandey SN; Modi DR; Kumar A; Mittal B
Hum Immunol; 2008 Jun; 69(6):360-7. PubMed ID: 18571008
[TBL] [Abstract][Full Text] [Related]
22. Analysis of EGF+61A>G polymorphism and EGF serum levels in Brazilian glioma patients treated with perillyl alcohol-based therapy.
da Silveira Fd; Lopes Bde A; da Fonseca CO; Quirico-Santos T; de Palmer Paixão IC; de Amorim LM
J Cancer Res Clin Oncol; 2012 Aug; 138(8):1347-54. PubMed ID: 22481252
[TBL] [Abstract][Full Text] [Related]
23. Case-Control Study on Impact of the Telomerase Reverse Transcriptase Gene Polymorphism and Additional Single Nucleotide Polymorphism (SNP)- SNP Interaction on Non-Small Cell Lung Cancers Risk in Chinese Han Population.
Xing YL; Liu F; Li JF; Lin JC; Zhu GD; Li M; Zhang CR; Niu YY
J Clin Lab Anal; 2016 Nov; 30(6):1071-1077. PubMed ID: 27154632
[TBL] [Abstract][Full Text] [Related]
24. T-cell immunoglobulin- and mucin-domain-containing molecule 3 gene polymorphisms and prognosis of non-small-cell lung cancer.
Bai J; Li X; Tong D; Shi W; Song H; Li Q
Tumour Biol; 2013 Apr; 34(2):805-9. PubMed ID: 23359271
[TBL] [Abstract][Full Text] [Related]
25. A genetic variant in long non-coding RNA MALAT1 associated with survival outcome among patients with advanced lung adenocarcinoma: a survival cohort analysis.
Wang JZ; Xiang JJ; Wu LG; Bai YS; Chen ZW; Yin XQ; Wang Q; Guo WH; Peng Y; Guo H; Xu P
BMC Cancer; 2017 Mar; 17(1):167. PubMed ID: 28253859
[TBL] [Abstract][Full Text] [Related]
26. Cyclooxygenase-2 genetic variants are associated with survival in unresectable locally advanced non-small cell lung cancer.
Bi N; Yang M; Zhang L; Chen X; Ji W; Ou G; Lin D; Wang L
Clin Cancer Res; 2010 Apr; 16(8):2383-90. PubMed ID: 20332326
[TBL] [Abstract][Full Text] [Related]
27. The associations of TERT-CLPTM1L variants and TERT mRNA expression with the prognosis of early stage non-small cell lung cancer.
Chen Z; Wang J; Bai Y; Wang S; Yin X; Xiang J; Li X; He M; Zhang X; Wu T; Xu P; Guo H
Cancer Gene Ther; 2017 Jan; 24(1):20-27. PubMed ID: 27982019
[TBL] [Abstract][Full Text] [Related]
28. [A study on the relationship between endoplasmic reticulum aminopeptidase2 genetic polymorphisms and non-small cell lung cancer in Yunnan Han population].
Zhou J; Ma Q; Guo C; Shi L; Yao Y; Yu J; Zhang X
Zhonghua Jie He He Hu Xi Za Zhi; 2014 Dec; 37(12):909-14. PubMed ID: 25609128
[TBL] [Abstract][Full Text] [Related]
29. The Contribution of
Chen GL; Shen TC; Chang WS; Tsai CW; Li HT; Chuang CL; Lai YL; Yueh TC; Hsia TC; Wang SC; Bau DT
Anticancer Res; 2018 Oct; 38(10):5671-5677. PubMed ID: 30275186
[TBL] [Abstract][Full Text] [Related]
30. Genetic variants in ERCC1 and XPC predict survival outcome of non-small cell lung cancer patients treated with platinum-based therapy.
Zhang R; Jia M; Xue H; Xu Y; Wang M; Zhu M; Sun M; Chang J; Wei Q
Sci Rep; 2017 Sep; 7(1):10702. PubMed ID: 28878296
[TBL] [Abstract][Full Text] [Related]
31. Polymorphisms in the FAS and FASL genes and survival of early stage non-small cell lung cancer.
Park JY; Lee WK; Jung DK; Choi JE; Park TI; Lee EB; Cho S; Park JY; Cha SI; Kim CH; Kam S; Jung TH; Jheon S
Clin Cancer Res; 2009 Mar; 15(5):1794-800. PubMed ID: 19240174
[TBL] [Abstract][Full Text] [Related]
32. Polymorphisms in epidermal growth factor receptor (EGFR) and AKT1 as possible predictors of clinical outcome in advanced non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitors.
Zhang X; Fan J; Li Y; Lin S; Shu P; Ni J; Qin S; Zhang Z
Tumour Biol; 2016 Jan; 37(1):1061-9. PubMed ID: 26269114
[TBL] [Abstract][Full Text] [Related]
33. Association of ERBB4 genetic polymorphism with the risk and prognosis of non-small cell lung cancer in Chinese Han population: A population-based case-control study.
Wang WP; Bian HB; Wang XZ; Liu L; Wei D
Medicine (Baltimore); 2021 May; 100(19):e25762. PubMed ID: 34106605
[TBL] [Abstract][Full Text] [Related]
34. SNPs in the TGF-β signaling pathway are associated with increased risk of brain metastasis in patients with non-small-cell lung cancer.
Li Q; Wu H; Chen B; Hu G; Huang L; Qin K; Chen Y; Yuan X; Liao Z
PLoS One; 2012; 7(12):e51713. PubMed ID: 23284751
[TBL] [Abstract][Full Text] [Related]
35. Functional promoter -1271G>C variant of HSPB1 predicts lung cancer risk and survival.
Guo H; Bai Y; Xu P; Hu Z; Liu L; Wang F; Jin G; Wang F; Deng Q; Tu Y; Feng M; Lu D; Shen H; Wu T
J Clin Oncol; 2010 Apr; 28(11):1928-35. PubMed ID: 20231684
[TBL] [Abstract][Full Text] [Related]
36. Association between the telomerase reverse transcriptase (TERT) rs2736098 polymorphism and cancer risk: evidence from a case-control study of non-small-cell lung cancer and a meta-analysis.
Wu H; Qiao N; Wang Y; Jiang M; Wang S; Wang C; Hu L
PLoS One; 2013; 8(11):e76372. PubMed ID: 24260099
[TBL] [Abstract][Full Text] [Related]
37. Single nucleotide polymorphisms of genes for EGF, TGF-β and TNF-α in patients with pancreatic carcinoma.
Zhang L; Wu G; Herrle F; Niedergethmann M; Keese M
Cancer Genomics Proteomics; 2012; 9(5):287-95. PubMed ID: 22990108
[TBL] [Abstract][Full Text] [Related]
38. Association between genetic variants in pre-microRNAs and survival of early-stage NSCLC.
Hong MJ; Choi YY; Jang JA; Jung HJ; Lee SY; Lee WK; Yoo SS; Lee J; Cha SI; Kim CH; Lee E; Jeon HS; Son JW; Park JY
J Thorac Oncol; 2013 Jun; 8(6):703-10. PubMed ID: 23470291
[TBL] [Abstract][Full Text] [Related]
39. CTLA-4 +49A>G polymorphism is associated with advanced non-small cell lung cancer prognosis.
Song B; Liu Y; Liu J; Song X; Wang Z; Wang M; Zhu Y; Han J
Respiration; 2011; 82(5):439-44. PubMed ID: 21832820
[TBL] [Abstract][Full Text] [Related]
40. Association of hypoxia inducible factor-1α polymorphisms with susceptibility to non-small-cell lung cancer.
Kuo WH; Shih CM; Lin CW; Cheng WE; Chen SC; Chen W; Lee YL
Transl Res; 2012 Jan; 159(1):42-50. PubMed ID: 22153809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]